Cover Image

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis

The pathophysiology and risk factors of nonalcoholic fatty liver disease (NAFLD) among lean is poorly understood and therefore investigated. We performed a meta-analysis of observational studies. Of 1175 articles found through searching from Medline/PubMed, Banglajol, and Google Scholar by two indep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alam, Shahinul, Eslam, Mohammad, Hasan, Nazmul, Anam, Kamrul, Chowdhury, Mohammad Abdul Baker, Khan, Md Abdullah Saeed, Hasan, Mohammad J., Mohamed, Rosmawati
Format:	Article
Published:	Wiley 2021
Subjects:	R Medicine RA Public aspects of medicine RC Internal medicine
Online Access:	http://eprints.um.edu.my/35002/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: A meta-analysis
by: Zain, Shamsul Mohd, et al.
Published: (2014)

Comparison between obese and non-obese nonalcoholic fatty liver disease
by: Chan, Wah Kheong
Published: (2023)

Nonalcoholic fatty liver disease and risk of early-onset vasomotor symptoms in lean and overweight premenopausal women
by: Cho, Yoosun, et al.
Published: (2022)

A global survey of physicians knowledge about nonalcoholic fatty liver disease
by: Younossi, Zobair M., et al.
Published: (2022)

Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
by: Alqahtani, Saleh A., et al.
Published: (2023)

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
by: Younossi, Zobair M., et al.
Published: (2024)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
by: Pitisuttithum, Panyavee, et al.
Published: (2020)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
by: Pitisuttithum, Panyavee, et al.
Published: (2020)

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease
by: Sun, Chao, et al.
Published: (2024)

Nonalcoholic Fatty Liver Disease A Unique Entity or Part of the Metabolic Syndrome or Both
by: Yip, Terry Cheuk-Fung, et al.
Published: (2023)

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
by: Chan, Wah Kheong, et al.
Published: (2018)

Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
by: Zhou, Yu‐Jie, et al.
Published: (2021)

Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: Data From the global non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) registry
by: Younossi, Zobair M., et al.
Published: (2022)

Prevalence of Ultrasound Diagnosed Nonalcoholic Fatty Liver Disease Among Rural Indigenous Community of Sarawak And Its Association With Biochemical and Anthropometric Measures
by: Cheah, W.L, et al.
Published: (2013)

Nonalcoholic fatty liver disease: A global perspective
by: Wong, Wei Kei, et al.
Published: (2021)

Hepatoprotective effects of a novel trihoney against nonalcoholic fatty liver disease: a comparative study with atorvastatin
by: Hamad Alfarisi, Hamad Abdulsalam, et al.
Published: (2020)

ACUTE FATTY LIVER IN PREGNANCY
by: Soe, Lwin, et al.
Published: (2020)

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
by: Chan, Wah Kheong, et al.
Published: (2017)

Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
by: Kamarajah, Sivesh Kathir, et al.
Published: (2018)

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
by: Wong, Vincent Wai-Sun, et al.
Published: (2019)

Accuracy of liver stiffness measurement in an Asian population with non-alcoholic fatty liver disease-a preliminary report
by: Mahadeva, S., et al.
Published: (2010)

Non-invasive assessment of metabolic dysfunction-associated fatty liver disease
by: Chandra Kumar, C. Vikneshwaran, et al.
Published: (2022)

acNASH index to diagnose nonalcoholic steatohepatitis: A prospective derivation and global validation study
by: Wu, Xi-Xi, et al.
Published: (2021)

Meta-analysis of donor-recipient gender profile in paediatric living donor liver transplantation
by: Wong, Zhen Yu, et al.
Published: (2022)

Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients
by: Zain, Shamsul Mohd, et al.
Published: (2020)

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
by: Eslam, Mohammed, et al.
Published: (2020)

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease
by: Chan, Wah-Kheong, et al.
Published: (2022)

Observations of scrotal mass, liver mass, haemolytic jaundice, and central vestibular disorder in brugia pahangi-infected dogs
by: Vinnie-Siow, Wei Yin, et al.
Published: (2019)

Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience
by: Rajaram, Ruveena B., et al.
Published: (2022)

Lifestyle interventions for non-alcoholic fatty liver disease
by: Ahmed, Idris Adewale, et al.
Published: (2019)

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease
by: Zain, Shamsul Mohd, et al.
Published: (2012)

Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease
by: Tan, Hwa Li, et al.
Published: (2020)

The effect of retinoic acid on non-alcoholic fatty liver disease (NAFLD) model
by: Ahmed Mohamed, Nawal, et al.
Published: (2021)

Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems
by: Leung, Howard Ho-Wai, et al.
Published: (2022)

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
by: Eslam, Mohammed, et al.
Published: (2021)

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease
by: Zhang, Xinrong, et al.
Published: (2020)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: An inter-national registry study
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2022)

Correlation between body composition and cardiorespiratory fitness in female adults of different Body Mass Index
by: Jaafar, Zulkarnain, et al.
Published: (2019)

Retinoic acid targeting DGAT2 in non-alcoholic fatty liver disease model
by: Ahmed Mohamed Ben-Amer, Nawal, et al.
Published: (2023)

Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia
by: Wong, Wei-Kei, et al.
Published: (2023)